New! View global litigation for patent families

US20120116495A1 - Compliant Venous Graft - Google Patents

Compliant Venous Graft Download PDF

Info

Publication number
US20120116495A1
US20120116495A1 US13351591 US201213351591A US2012116495A1 US 20120116495 A1 US20120116495 A1 US 20120116495A1 US 13351591 US13351591 US 13351591 US 201213351591 A US201213351591 A US 201213351591A US 2012116495 A1 US2012116495 A1 US 2012116495A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
vein
support
graft
tubular
compliance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13351591
Inventor
Peter P. Zilla
Nasser Rafiee
Deon Bezuidenhout
Thomas Franz
Mark Yeoman
Hellmut Bowles
Nareak Douk
Michael F. Wolf
Original Assignee
Zilla Peter P
Nasser Rafiee
Deon Bezuidenhout
Thomas Franz
Mark Yeoman
Hellmut Bowles
Nareak Douk
Wolf Michael F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625Vascular tissue, e.g. heart valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure

Abstract

A venous graft for replacement of a section of an artery and methods of making the graft. The graft comprises a flexible, resilient, generally tubular external support and a vein segment carried within and having an ablumenal surface in contact with and supported by the tubular support, the venous graft being capable of resilient radial expansion in a manner mimicking the radial compliance properties of an artery.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application is a continuation of U.S. Nonprovisional patent application Ser. No. 12/388,702 titled “Compliant Venous Graft” and filed on Feb. 19, 2009, which is a divisional of U.S. Nonprovisional patent application Ser. No. 10/834,360, now U.S. Pat. No. 8,057,537, titled “Compliant Venous Graft” and filed on Apr. 28, 2004, which itself claims priority to U.S. Provisional Patent Application Ser. No. 60/466,226 titled “Compliant Venous Stent” and filed on Apr. 28, 2003, the contents of which being incorporated herein in their entirety.
  • FIELD OF THE INVENTION
  • [0002]
    This invention involves a venous graft involving a vein segment and a supportive sheath chosen to provide the graft with mechanical compliance properties which resemble those of a healthy native artery.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Various types of vascular prostheses are known or available. Commercially available synthetic vascular grafts in use are commonly made from expanded polytetrafluoroethylene (e-PTFE), or woven, knitted, or velour design polyethylene terephthalate (PET) or Dacron®. These prosthetic vascular grafts may have various drawbacks. When used for repairing or replacing smaller diameter arteries, these grafts may fail due to occlusion by thrombosis or kinking, or due to an anastomotic or neointimal hyperplasia (exuberant cell growth at the interface between artery and graft). Another problem may involve expansion and contraction mismatches between the host artery and the synthetic vascular prosthesis, which may result in anastomotic rupture, stimulated exuberant cell responses, and disturbed flow patterns and increased stresses leading to graft failure.
  • [0004]
    Problems also exist with the use of autologous saphenous vein grafts in these applications. Use of autologous saphenous vein grafts to bypass blockages in coronary arteries has become a well-established procedure. However, their success in the long term has been limited. In the coronary position, the literature reports a low (45-63%) patency of vein grafts after 10-12 years. It is believed that these failures result from remodeling of the implanted vein in response to greatly increased internal pressure, that is, as the vein is required to function as an artery. In general, arteries have substantial musculature and, although able to expand diametrically in response to increased internal pressure, are capable of withstanding normal arterial pressure variances. Veins, on the other hand, are not required to withstand arterial pressure variances and are relatively incapable of withstanding the higher arterial pressures without substantial bulging. In this regard, the nominal venous diameter seen under nominal venous pressure is seen to approximately double upon exposure to arterial pressure.
  • [0005]
    Increases in lumenal diameter of these magnitudes in vein segment implants are accompanied by increases in tangential stress. Tangential stress has been shown to be proportional to the lumenal radius-wall thickness ratio. In healthy arteries, this ratio remains constant across multiple species. However, this does not occur in veins. It is believed that a vein's smooth muscle cells increase their growth rate and secrete extra-cellular matrix components in response to such increases in tangential stress. This becomes a remodeling response, and is likely an attempt by the vein to reduce the lumenal radius-wall thickness ratio, and consequently the tangential stress. However, it appears that these reactions overcompensate in the veins, resulting in the phenomenon of neointimal hyperplasia yielding grossly thickened and stiff graft walls. As the dilation of the vein segment continues, the resulting mismatch between the vein and artery diameters may lead to disturbance of flow patterns, which may also favor the formation of thrombi.
  • [0006]
    A venous graft that reduces or eliminates such failings in the prior art is required.
  • SUMMARY OF THE INVENTION
  • [0007]
    It has now been found that a vein segment, if externally supported by an appropriate , flexible, radially-resiliently tubular support, can function, in much the same fashion as the artery to be replaced. That is, it functions without undue bulging or aggravated mismatching phenomena leading to graft failure. Unless otherwise indicated, the term “compliance” means the ratio of the diameter change of a vessel as it expands in the radial direction in response to a given change in vessel pressure, and the values for compliance referred to below result from dynamic, in vitro testing. As described in greater detail below, the compliance of venous graft is largely dependent upon the compliance of the external, radially resilient support.
  • [0008]
    The invention in one embodiment, accordingly, relates to a flexible, resilient, generally tubular external support within which may be supported a vein segment to form a venous graft. The tubular support is capable of resilient radial expansion in a manner mimicking the compliance properties of an artery, and compliance figures in the range of 3 to 30%/100 mm Hg are appropriate. The tubular support may be formed of a knitted or woven fiber mesh that is so formed as to exhibit the needed compliance properties.
  • [0009]
    The invention in certain embodiments provides a venous graft for replacement of a section of an artery. The graft comprises a flexible, resilient, generally tubular external support and a vein segment carried within and having an ablumenal surface in contact with and supported by the tubular support, the venous graft being capable of resilient radial expansion in a manner mimicking the compliance properties of an artery. Compliance figures in the range of 3 to 30%/100 mm Hg are appropriate. The tubular support may take the form of a fiber mesh, such as a knitted, braided or woven mesh, the fibers of which may, if desired, be appropriately crimped to provide the required resiliency and compliance.
  • [0010]
    In other embodiments, the invention relates to a method for producing a venous graft for use in replacing a section of an artery. A segment of a vein is provided, and is sheathed in a generally tubular support in supportive contact with the ablumenal surface of the vein segment. The support is sufficiently flexible and radially resilient as to provide the resulting graft with compliance properties mimicking the compliance properties of an artery. Sheathing of the vein segment within the tubular support may be accomplished by supporting the generally tubular support upon an exterior surface of an applicator having an internal passage within which is positioned the vein segment, and removing the applicator to permit the tubular support to come into supportive contact with the ablumenal surface of the vein segment. Axial dimensional changes in the tubular support may be controlled as necessary to provide the venous graft with the desired compliance properties mimicking arterial compliance properties.
  • [0011]
    Other embodiments of the invention relate to venous grafts that include a flexible, resilient, generally tubular external support formed of a shape memory alloy, and a vein segment carried within and having an ablumenal surface in contact with and supported by the tubular support. The shape memory support may be placed around a vein segment when the shape memory material is in a first enlarged configuration. The tubular support comes into supportive contact with the ablumenal surface of the vein when the support is transformed, as by a temperature increase, into a second configuration different from the first configuration. The shape memory support in its second configuration may exhibit superelastic properties and in any event is sufficiently flexible and resilient as to provide the venous graft with compliance properties mimicking the compliance properties of an artery. Compliance figures in the range of 3 to 30%/100 mm Hg are appropriate. The tubular support may take the form of a wire mesh made of shape memory alloy, such as a knitted or woven mesh, the wires of which may, if desired, be appropriately crimped to provide the required resiliency and compliance.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0012]
    FIG. 1 is a pressure versus diameter graph typifying the characteristics of a native vein, native artery, a non-compliant stented vein, and a compliant stented vein;
  • [0013]
    FIG. 2 is a schematic cross-sectional view of an artery;
  • [0014]
    FIG. 3 is a representative pressure versus strain graph;
  • [0015]
    FIG. 4 is a pressure versus graft diameter graph;
  • [0016]
    FIG. 5 is a photograph of a tubular support in a first configuration, shown in an axially compressed and radially expanded configuration and supported on a plastic tube;
  • [0017]
    FIG. 6 is a photograph of the tubular support of FIG. 5 in an axially elongated and radially reduced configuration to conform to a vein outer diameter;
  • [0018]
    FIG. 7 is a side view of the graft of FIG. 6, showing a length-governing element;
  • [0019]
    FIG. 8 is a schematic view of braided elements;
  • [0020]
    FIG. 9 is a perspective view of a braided tubular support;
  • [0021]
    FIG. 10 is a schematic view of knitted elements;
  • [0022]
    FIG. 11 is a side view of a section of a knitted tubular support;
  • [0023]
    FIG. 12 is a view of angular pre-braiding crimped elements;
  • [0024]
    FIG. 13 is a perspective, schematic view of an angular pre-braiding crimped tubular support;
  • [0025]
    FIG. 14 is a view of rounded pre-braiding crimped elements;
  • [0026]
    FIG. 15 is a view of angular pre-knitting crimped elements;
  • [0027]
    FIG. 16 is a view of rounded pre-knitting crimped elements;
  • [0028]
    FIG. 17 is a broken-away, perspective view of a post-braiding crimped tubular support;
  • [0029]
    FIG. 18 is a broken-away, perspective view of a venous graft showing a portion with anti-fraying element;
  • [0030]
    FIG. 19 is a broken-away, perspective view of one embodiment utilizing an applicator for assembling a venous graft;
  • [0031]
    FIG. 20 is a broken-away, perspective view of the use of a modified applicator for assembling a venous graft; and
  • [0032]
    FIG. 21 is a photographic, perspective view of a section of a knit tubular support.
  • DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
  • [0033]
    Applicants have recognized that significant deficiencies attend to the past methodologies and devices relating to the increased pressures experienced by vein grafts utilized in arterial positions. The increased pressures lead to excessive dilation of vein grafts in arterial circulation, leading to the development of intimal hyperplasia, which causes occlusion of the vessel.
  • [0034]
    Intimal hyperplasia is believed to be a primary reason for vein graft failure. In this context it is known that intact endothelium acts in a manner to protect against the proliferation of underlying vascular smooth muscle cells, known as VSMC. The intact endothelium also plays a role in VSMC contractile responses. The VSMC have also been shown to release factors with long term physiological effects on the endothelial cells, including maintenance of a non-proliferative state. By comparison, the pathogenesis of intimal hyperplasia in a vein graft may follow the sequence of dilatation under arterial pressure; overstretching to maximum capacity; disruption of borders of endothelial cells; rupture of internal elastic membranes; migration of smooth muscle cells into the intimal layer and resultant unbalanced proliferation; atrophy of media and further consolidation of stiffness; and graft arteriosclerosis with traumatic media necrosis and atrophy, as well as pathological surface and wall stress and strain. These phenomena may result in a decrease in vein graft patency within six years. Intimal hyperplasia may be observed in such grafts from about 16 months, while anastomotic intimal hyperplasia may occur at about 18 months, and arteriosclerosis may occur from about 45 months.
  • [0035]
    Others have attempted to overcome certain of these problems by use of metallic or polymeric external structures designed to arrest the dilation of the vein graft. FIG. 1 graphs blood pressure against vessel diameter, with D0 representing the vessel diameter at zero pressure. As shown in this graph, lines 16, 18 represent the normal diastolic, i.e. low (80 mm Hg) and normal systolic, i.e. high (120 mm Hg) physiological blood pressure range for humans. Point 21 may represent the diameter of an artery (DA) at 100 mmHg, and point 23 may represent the diameter of a vein (DV) at the same pressure of 100 mmHg. An unstented native artery reacts to pressure loading as shown at line 32, and an unstented vein reacts to the same loading as shown at line 35. The use of known stents with vein grafts results in movement of line 35 in the direction shown by arrow 38, resulting in the approximate profile indicated at line 42 showing the response of a pressure loaded vein and non-compliant stent combination. Although this prevents over-dilation, and some advantage accrues, this may lead to further unhealthy sequelae. Also, to the extent that vein-stent combination devices may be shown to limit some of the dilation and intimal hyperplasia in the mid-graft region, they may not be able to prevent intimal hyperplasia at the anastomoses. This can be a significant problem for vein grafts that are transplanted into the arterial circulation vasculature. Prior attempts to resolve these problems fail to recognize the full implications of a vein being used in these situations. Accordingly, factors in the design of a vein-graft that may have a significant impact on its long term patency may have been missed.
  • [0036]
    One important factor in proper remodeling is that of proper cyclic stretch. Applicants are able to incorporate this concept into vein-stent grafts of the invention. In similar manner, the role of vascular endothelial growth factor (VEGF) in vascular smooth muscle cells may be very important to the design of a preferred arterial vein-stent graft. It is known that low concentrations of VEGF may play a role in preserving and repairing the arterial lumenal endothelial layer. Further, it is suggested that activation of the VEGF receptor KDR is affected by cyclic stretch. Applicants believe that the phenomenon of upregulation of VEGF expression by physiological stretching of vascular smooth muscle cells is one reason for redesigning a vein-stent graft which has improved, controllable cyclic stretch features.
  • [0037]
    A further consideration is the influence of tensile stress/strain on the structure and organization of smooth muscle cells during development and remodeling, particularly as to the orientation of such cells. In a larger topographical sense, this may also relate to the role of blood flow in the formation of focal intimal hyperplasia in known vein grafts, including inducement of eddy blood flow at locations of graft-host diameter mismatch.
  • [0038]
    These considerations and deficiencies can be addressed with the various structures and methodologies of the present invention in which a vein graft is provided that exhibits compliance properties mimicking those of healthy arteries. Radial expansion and contraction of the graft is permitted in a manner that mimics the radial expansion and contraction of an artery to at least closely approach the desired result in which the vein graft, its connections to adjacent arterial ends or stumps, and the adjacent arterial portions tend to expand and contract in a similar manner, to thereby substantially avoid anastomotic compliance mismatches. This is accomplished through the use of a flexible, resilient, generally tubular external support that engages the ablumenal surface of a vein segment carried within the support, the support being so fabricated as to functionally provide the graft with the compliance properties of an artery.
  • Compliance Properties
  • [0039]
    As noted earlier, compliance is the ratio of the diameter change of a vessel in the radial direction to a given change in vessel pressure, and the values for compliance referred to below result from dynamic, in vitro testing. Compliance values are reported here as percentage changes in the internal diameter of a vessel per a 100 mm Hg change in vessel pressure, as measured in the range of normal blood pressures, that is, from about 80 mm Hg to about 120 mm Hg. In the laboratory, it is convenient to measure compliance through the use of an elongated balloon structure over which a candidate tubular support is positioned. Distilled water at about 37° C. is pumped into the balloon to cause it to inflate, and the pressure within the balloon is cycled between 0 mm Hg and 140 mm Hg at a frequency of about 72 cycles per minute to mimic a normal pulsatile blood flow. The change in internal volume is measured between 0 mm Hg and 140 mm Hg to provide pressure/volume data. From this data is subtracted the pressure/volume data resulting from repeating the procedure with the balloon alone, and from the resulting pressure/volume data the percentage change in the internal diameter of the tubular support between 80 and 120 mm Hg can be calculated. It is convenient to express this radial compliance value as %/100 mm Hg.
  • [0040]
    The compliance of an implanted venous graft may be measured in vivo through the use of ultrasound techniques in which the vein graft is visualized in a cross-sectional view and the dimensional change of the vessel with varying blood pressure is recorded for at least one and usually a number of cardiac cycles. The cross-sectional lumenal area of the vein graft is measured for the smallest cross-sectional configuration and the largest cross-sectional configuration for one cardiac cycle. The smallest cross-sectional configuration of the vein graft lumen is associated with diastolic blood pressure whereas the largest cross-sectional configuration is associated with systolic pressure. The cross-sectional lumenal area values for diastolic and systolic blood pressure are used to calculate the lumenal diameter values and the vein graft compliance. Compliance values of a venous graft measured in vivo often are slightly larger that the compliance values measured in the laboratory, and the compliance values referred to herein are laboratory values resulting from the in vitro measurements described above
  • [0041]
    FIG. 2 is a sectional representation of vascular tissue useful for illustrating the relation of the natural arterial structure with the prosthetic venous graft structure of the invention. The natural adventitial layer 95 of an artery 98 is comprised of two main tissue types that contribute to the mechanical properties of the natural artery, namely elastin and collagen. The mechanical properties of these two soft tissue components are described in Table I below:
  • [0000]
    TABLE I
    Soft Tissue Elastic Modulus (Pa) Max Strain (%)
    Elastin 4 × 105 130
    Collagen 1 × 109 2-4
  • [0042]
    As shown in the above table, these two soft tissue types have large differences in mechanical properties. Elastin is very elastic, and collagen is very stiff in comparison. These two tissue types are combined in the adventitial layer to produce a non-linear elastic response. As shown in FIG. 3, the combined effect of the characteristics of elastin 101 and collagen 104 (having a greater role at higher strains) results in a non-linear response curve (shown loading at 135 and un-loading at 137) within the physiological pressure range of a natural artery between about 80-120 mm Hg. This characteristic of pulsatile expansion and contraction of arteries requires fine mechanical compliance of any prosthetic graft, i.e., a close mimicking by the prosthetic device of the mechanics and timing of the natural artery distending and reshaping under change in blood pressure.
  • [0043]
    From an engineering standpoint, the following relationships may be helpful from a design standpoint in producing venous stent grafts of the invention.
  • [0000]
    C d = Δ D D diastolic Δ P × 100 × 100 mm Hg
  • [0000]
    in which Cd is compliance, P is blood pressure, D is vessel diameter, and ΔD represents the diameter change between systolic and diastolic pressures.
  • [0044]
    The stiffness of blood vessels is stated as a stiffness index (β), and is a measure of the changes of curvature and diameter, stated as:
  • [0000]
    β = ln P systolic P diastolic Δ D D diastolic = D diastolic ln P systolic - ln P diastolic Δ D
  • [0045]
    A related characteristic of blood vessels is that of elastic modulus (K), which is considered a measure of stiffness, and is stated as:
  • [0000]
    K = V diastolic Δ P Δ V d diastolic Δ P Δ D 1 C
  • [0000]
    in which C is compliance. In terms of diametric compliance, as an example,
  • [0000]
    K = D diastolic P systolic - P diastolic D systolic - D diastolic = D diastolic Δ P Δ D
  • [0046]
    FIG. 4 shows that the Elastic Modulus (K), as defined in above equations, is proportional to the secant S1 of the pressure-diameter curve PD1 , plotted on a linear scale (left y-axis in FIG. 4), between diastolic and systolic pressure. The slope, (Psyst−Pdiast)/(Dsyst−Ddiast), of the secant S1is a good approximation to the slope of the pressure-diameter curve PD1 in that pressure range. From the above equations for the Elastic Modulus (K) it can be appreciated that the Elastic Modulus (K) is not equal to the slope of the secant S1 but is proportional to the slope by a factor Ddiastolic. Compliance (Cd) is approximately proportional to the Elastic Modulus (K) hence it is approximately proportional to the inverse of the secant S1 of the pressure-diameter curve PD1 between diastolic and systolic blood pressure.
  • [0047]
    The stiffness index (β) is proportional to the secant S2 of the pressure-diameter curve PD2 between diastolic and systolic blood pressure when the pressure-diameter curve is plotted on a logarithmic pressure scale (right y-axis in FIG. 4). The slope of the secant S2 is (ln Psyst−ln Pdiast)/(Dsyst−Ddiast) and is a good approximation to the slope of the pressure-diameter curve PD2 in that pressure range. It can be again appreciated, from the above equations for the Stiffness Index (β) that the Stiffness Index (β) is not equal to the slope of the secant S2 but is proportional to the slope by a factor Ddiastolic.
  • [0048]
    Compliance data of natural human vessels is categorized by vessel type and by age of the vessel (i.e., age of patient). For example, a common carotid artery has about a 6.6%/100 mm Hg compliance value. The values for a superficial femoral artery and a femoral artery are 6-10%/100 mm Hg. A value for a saphenous vein, however, is about 4.4%/100 mm Hg, while an aorta ranges generally from about 20-50%/100 mm Hg, depending on the location. Also, the lengths of grafts according to location in the body must be considered, and substantial lengthwise variance in graft lengths is not uncommon. It is also known that the diameter of various arteries change over time, and this may have a significant impact on overall compliance values. Returning to FIG. 1, line 80 represents the pressure-diameter data that certain embodiments of venous grafts of the invention seek to emulate, wherein the compliance properties of a native artery (line 32) is closely mimicked.
  • Support Materials and Manufacture
  • [0049]
    The radially resilient support may be manufactured from any biologically acceptable material that possesses the ability to be shaped into a tubular structure having the required compliance. Polymeric fibers may be employed, such as polyurethanes, polyethylene terephthalate, polypropylene, and polytetraflouroethylene, and good results may be obtained through the use of wires of such metals as stainless steel and cobalt-chromium alloys. Wires made of shape memory alloys such as nitinol may be used to advantage. Shape memory elements or filaments may be made of one or more shape memory materials as exemplified in the following table, it being understood that this is not to be considered an exhaustive list. Also, any metal or metal alloy may be coated with a polymer for improved biocompatibility, recognizing that the polymer may or may not be biodegradable.
  • [0000]
    ALLOYS POLYMERS
    Ag—Cd Two component system based on
    oligo(Σ-caprolactone)dimethacrylate and
    N-butyl acrylate
    Au—Cd Polyurethanes
    Cu—Al—Ni Polynorborenes
    Cu—Sn Poly(ether ester)s consisting of
    poly(ethylene oxide) and poly(ethylene
    terephthalate) (EOET copolymers)
    Cu—Zn Ethylene vinyl acetate copolymers
    Cu—Zn—Si Polystyrene polybutadiene copolymer
    Cu—Zn—Sn
    Cu—Zn—Al
    In—Ti
    Ni—Al
    Ni—Ti
    Fe—Pt
    Mn—Cu
    Fe—Mn—Si
  • [0050]
    With respect to shape memory alloys, other design considerations include temperatures, different diameters and radial compliance, shape transformation dimensional changes, and wire thicknesses. Generally, shape memory alloys and shape memory polymers may have transformation temperatures which are below physiological temperatures, i.e., 37° C., to ensure self-righting responses. Preferably, transformation temperatures will also be above room temperature to ensure that the shape memory material reinforcing does not need to be refrigerated for storage purposes. Thus, the ideal shape memory transformation temperatures will likely be between 21° and 37° C. This transition may either be a two-way or a one-way directional transition, with a currently preferred embodiment including a two-way directional transition. The transition temperature range can either be a short, i.e. 0.5° C., or a long transition temperature range, i.e. 10° C., where the shape is proportionally regained over this temperature range. For example, for a desired temperature transition to be 100% complete at 25° C. but with it starting at 20° C., then this would yield a temperature range of 5° C. The changes in radial diameter due to the shape memory material experiencing transformation dimensional changes is preferably in a range of from 5% to 30%.
  • [0051]
    An embodiment of a tubular support utilizing a shape memory alloy is illustrated in FIGS. 5 and 6. FIG. 5 shows an arterial reinforcement tubular support 77 formed of one or more shape memory material elements 165. These elements are braided, but may also be knitted, into a generally tubular structure designed for placement around a portion of a vein to produce an arterial graft. In this example, a shape memory alloy is employed because of its so-called “superelastic” properties rather than its ability to undergo temperature-induced phase changes, although some phase change from austenite to stress-induced martensite may occur. In FIG. 5, the braided tube is positioned on a hollow plastic straw as representing a vein segment, and has been compressed axially to produce an increase in diameter. By extending the braided tube axially, as shown in FIG. 6, the tube becomes reduced in diameter to provide support to the vein segment.
  • [0052]
    The shape memory braided material shown in FIGS. 5 and 6, if used also for its phase transformation properties, may be supplied in a first configuration (which may be in the martensite phase) which can be easily manipulated to receive a vein segment 86 within the structure, and a second configuration (shown in FIG. 6, which may be in the higher temperature austenite phase) which has a “remembered” narrower diameter configuration to provide support to the vein segment. The contact of inner surfaces 170 of the structure with ablumenal surfaces 175 of the vein segment 86 is shown also in FIG. 7. The resilience of shape memory materials can be controlled by altering compositions, tempering procedures, wire diameters, etc., so that a tubular support fashioned from this material may mimic (when combined with the minimal mechanical values of a vein segment) the compliance values of a host artery in order to optimize the venous graft-artery interaction. This aspect of compliance mimicking has components of expansion, recoil, timing, and tissue remodeling. In this example, the vein-stent compliance values are chosen to closely mimic those of a healthy native artery. Whereas the shape memory wires are shown as braided in these figures, they may also be knit, and in fact the knit configuration appears to be offer certain advantages.
  • [0053]
    Radially resilient tubular supports may be knit from metal wire, such as stainless steel and cobalt-chromium alloys. Metal wires ranging in diameter from about 25 to 150 micrometers are appropriate for knit supports with diameters in the range of 35 to 50 micrometers being particularly useful, although larger or smaller diameters may be employed as desired. For braided tubular supports, metal wires ranging in diameter from about 37 to about 170 micrometers are appropriate, although larger or smaller diameters may be employed.
  • [0054]
    Knitting procedures may be performed by known methods using, for example, a LX96 knitting machine manufactured by the Lamb Knitting Machine Corporation. Favorable radial compliance and tubular dimensional properties may result from knitting the tubular structure in a manner providing loops that alternate in the circumferential direction between larger and smaller loops, as shown in FIG. 21. In this Figure, smaller loops 250 are shown alternating circumferentially with larger loops 251. Such alternating loop sizes typically present themselves visually as longitudinal stripes extending axially along the tubular support, as the adjacent loops of each size align in the longitudinal axis. Each closed end of the loop may be either rounded or generally square-shaped or variations in between, and, the sides of the loop may turn outward, be parallel, or turn inward. The latter design has shown some advantage in acting like a spring and assisting in the stability of the overall dimensions of the tubular structure, and maintaining its compliance characteristics.
  • [0055]
    The knitted or braided tubular support may then be subjected to crimping to provide crimps extending, for example, about the circumference of the tubular support (that is, in the manner shown in FIG. 17). One way of doing this is through the use of an axially fluted mandrel that is inserted into the tube and is pressed outwardly against a wall of the tube to force the wall against a complementary shaped outer female mold to bend the knitted or braided wires and to form a circumferential crimp, the crimp resulting from each flute or raised ridge of the mandrel extending axially of the support.
  • [0056]
    A compliant venous graft using various metals or polymers for the tubular support may be provided in several ways. Embodiments may be advantageously provided in knitted form. FIGS. 8 and 9 show material 165 in a braided configuration, and FIGS. 10 and 11 show material 165 in a knitted configuration. Mechanical characteristics of the tubular support may be enabled by the type of shaping and relational structures formed on the elements making up the knit or braided structures. It is contemplated that a technique involving crimping of the material 165 to achieve angular crimps (shown in FIGS. 12 and 13), formed prior to the braid or knit construction, and rounded crimps (shown in FIG. 14) may provide acceptable results. Crimping techniques that may be appropriate with pre-knit configurations, are shown in FIG. 15 (angular crimps) and FIG. 16 (rounded crimps). Another technique for achieving certain performance characteristics of braided or knitted shape memory materials 165 is to perform crimping after braiding or knitting, i.e. post-braiding or post-knitting. FIG. 17 shows one embodiment of material 165 formed in a braided configuration and having a post-braided crimping operation applied to form a crowned pattern to achieve desired crimp characteristics.
  • [0057]
    Crimp angle and pitch density may be important variables in certain embodiments of the current design of the tubular supports. It is understood, however, that certain advantages of this invention may still be achieved without use of crimping. Ranges of crimp angle are preferably from about 10° to 85° to the line of lay of the reinforcing wire or braid. The crimp size may vary from 0.01 to 5 mm in length. It is desired that the braid or helical wires have a pitch angle that may vary from about 5-85° to the axial length of the vein graft.
  • [0058]
    Applicants have identified certain crimping techniques that relate to crimping either before or after braiding or knitting. For example, in post-braid crimping the material braids are produced according to existing techniques, after which macroscopic longitudinal crimping is imparted to the tubular mesh using a post-braid crimping tool. However, according to the material and specific configuration of the stent, if the post-braid crimping of braided tubes does not achieve sufficient compliance then alternate methods are possible. One example is to effect pre-braid crimping, thereby setting the memory of a shape memory material in a crimped configuration and subsequently straightening the material before braiding. The crimp is thus induced upon exposure to physiological temperatures.
  • [0059]
    The external tubular support adjusts the mechanical and geometrical properties of the vein graft to match or mimic healthy arterial properties and therefore adapt to the arterial pressure of the host artery. Accordingly, this results in substantial matching of the lumen of the vein graft and the host artery, the substantial matching of compliance of the vein graft and the host artery, and substantial matching of the radius to wall thickness ratio (r/wt) of the vein graft to the host artery. As noted above, optimization of the vein-stent compliance should ensure that the vein-stent graft mimics the behavior of arteries regarding the non-linear stiffening with increasing diameter due to elevated blood pressure, “locking” at a maximum pressure, and then demonstrating dynamic recoil in a timely manner.
  • [0060]
    When venous grafts utilizing knit or braided tubular supports are cut at angles suitable for end-to-end anastomoses, either at generally right angles or in scallop-like shape, the ends of the supports may experience fraying (see, for example, FIG. 17). Certain methods and structure are helpful to eliminate such fraying. In one embodiment, adjustable rings 210 of bioabsorbable or biodegradable material are placed generally circumferentially around a portion of the material 165, and in contact with external surfaces 217, as shown in FIG. 18. The number of rings may be varied as needed. The location of the rings may be adjusted to the position of anastomoses where vein and tubular support need to be cut. The cut or suture may be carried out through the ring, and the ring may be absorbed or degraded over a predetermined time, as desired.
  • [0061]
    Another embodiment of a structure to prevent fraying of a knit or braided tubular support when it is cut is the use of polymer coating for the fiber mesh. This feature may also provide the benefit of preventing gluing of joints and contact zones of elements of the stent. However, use of the radially compliant tubular support as a reinforcing structure may advantageously involve bonding of the ablumenal surface of a vein segment to confronting internal surfaces of the support. This attachment or connection may be accomplished through the use of a glue or other material having adhesive or connecting characteristics. In one embodiment, a fibrin glue or other material having adhesive or connective characteristics may be sprayed on designated portions of the vein (as exemplified at 283 in FIG. 20) and/or the tubular support. Another embodiment includes placement of a material on designated portions of the lumenal surfaces of the tubular support so as to provide the characteristics of contact adhesion and/or bonding when these portions contact the vein. However, the glue or other material must not inhibit the function of the tubular support. It is desirable that the contact of the tubular support with the ablumenal vein segment surface be reasonably uniform along the length of the support, and that regions of much higher force of the support against the ablumenal wall of the vein be avoided.
  • [0062]
    Applicants have further recognized the need for a device to facilitate assembly of the radially compliant tubular support and a vein segment. It is desirable that such an applicator should not obscure the stent lumen, and that it should allow for easy insertion of the vein. It is further recognized that a design whereby diameter is increased by length compression, as in a braided configuration, would allow easy slipping of the tubular support over a vein. FIG. 19 illustrates this concept in combination with an applicator 279 to apply the braided support 284 to a vein 86. This longitudinal braid contraction phenomena (shown earlier in FIGS. 5 and 6), and which must be carefully managed at the time of joining the vein to the stent, is likely quite useful to achieving the goals of an applicator 279, as noted above. This applicator may also facilitate placement of anti-fraying rings 210. In one embodiment, the method of using the applicator comprises the steps of: providing the means of longitudinally contracting a stent; holding the stent in the contracted position with increased stent diameter resulting; inserting a vein into the stent lumen; and distending the stent longitudinally while the vein is inserted simultaneously until the stent is slipped over the desired portion of the vein. Further design considerations must ensure that the stent will not be fixed to the vein in a longitudinally over-distended or contracted state, so as to ensure that the predetermined mechanical stent properties remain viable.
  • [0063]
    FIG. 20 shows an embodiment in which a tubular support 185 is received along the outer surface of surface of an applicator 281 having an internal passage, and, while passing the vein segment 86 from within the applicator passage, the tubular support is drawn onto the ablumenal surface of the vein segment. The applicator here may be a thin walled tube resembling a soda straw.
  • [0064]
    It is important that the support be applied to a vein at a predetermined length which is associated with a particular desired compliance. A length-defining support feature or system should ensure a predetermined support length. This is particularly true with respect to braided supports, and perhaps less important with knit supports in which radial resilience is less dependent upon the amount to which the support is extended axially.
  • [0065]
    In a braided support, and to a much lesser extend in a knit support, compliance and related mechanical properties are linked to the support length through the pitch angle. Imparting a change in length results in a change in pitch angle and compliance. However, the compliance of the support is a mandatory characteristic which is optimized, as noted above, to mimic the compliance of a normal healthy host artery. When applying a support to a vein segment, it is important to accurately accommodate the predetermined tubular support length, even after longitudinal contraction of the support for the attachment of the support to the vein.
  • [0066]
    With braided, and to a much lesser extent knit supports, axial support length may be controlled, for example, through the use of an axially extending, relatively inextensible element, (as for example the thread 78 in FIG. 7), that restrains the tubular support from unwanted axial extension. The thread may be woven through the support mesh and may be fastened, as by welding, to the various wires that the thread encounters along the length of the support so that as the support is stretched axially, the extent of axial elongation is controlled by the thread as the thread is drawn taut. Moreover, this feature may enable a length of the tubular support to be divided into portions of appropriate length, with the permitted axial extension of each portion controlled by the section of thread within it. As presently envisioned, a vein segment may be sheathed in a tubular support as discussed in detail above, with the intent of cutting out a smaller segment of the resulting venous graft for use in the surgical replacement of an artery, and the venous graft that is thus used will have vein and tubular support ends that are coextensive.
  • [0067]
    Various generally tubular external wire mesh supports were fabricated from metal wires by braiding and by knitting, some being crimped and others not, and the diametrical compliance of each was measured using the in vitro diametrical compliance testing outlined above. The measured compliance values were dependent upon many variables, including wire size, tightness of braid or knit, etc. The following values were obtained:
  • [0000]
    Compliance
    Design %/100 mmHg
    A Braided Non-crimped 0.9
    B Braided Crimped 5.6
    C Braided Crimped 1.8
    D Knitted Non-crimped 3.4
    E Knitted Crimped 7.9
    F Knitted Crimped 8.0
    G Knitted Non-crimped 10-21
    H Knitted Non-crimped  9-21
    I Knitted Non-crimped  16->30
    J Knitted Non-crimped >30
    K Knitted Non-crimped 10-16
    L Knitted Non-crimped 21-29
    M Knitted Non-crimped 22-28
    N Knitted Non-crimped >30
    O Knitted Non-crimped 10-15
    P Knitted Non-crimped  9-11
    Q Knitted Non-crimped 13-24
    R Knitted Non-crimped >30
  • [0068]
    A surgical procedure is proposed for use of the venous graft disclosed herein. This procedure, which may also be viewed as a simple method for placement of a venous reinforcement structure, includes, in this example, application of the compliant external tubular support during the procedure of vein excision. In many instances, vein excision is considered a standard part of a surgical operation, which is usually done by an assistant at a time when the surgeon is still in the preparatory phase of the operation.
  • [0069]
    In one embodiment, an initial step includes dissection and freeing of a saphenous vein. The saphenous vein is dissected free in a standard way, leaving it in situ while ligating and cutting off its branches. The second step involves testing for potential wall leaks of the vein. In order to test the isolated saphenous vein for potential leaks, it is normally cannulated distally and cold heparinised blood is injected while the proximal end is occluded. This inflation of the vein (using old techniques) with a syringe creates pressures of up to 350 mm of Hg and is often a main reason for traumatic damage of the vein wall. Therefore, a pressure limiting mechanism may be positioned between the vein cannula and the syringe. The external tubular support cannot be applied yet because leaks in the vein wall need to be freely accessible for repair. Therefore, no over-distention protection is placed around the vein yet, necessitating the limitation of the inflation pressure to a level suitable for detecting any leaks of concern but less than a level deemed to cause unacceptable damage, such as, for example, in one embodiment, 15 mm of Hg, the pre-maximal dilatation pressure for veins. The tissue remodeling functions of applicants' invention become more critical in view of the importance of leak testing and the reality of possible damage to the intimal layer in the vein during even the most carefully performed leak testing.
  • [0070]
    The next step involves assembling the harvested vein segment and an external tubular support of this invention. In this step, the tubular support (typified here as a knit support) is mounted on a tube or straw-like applicator within which is positioned the vein segment. See FIG. 20. The straw is then removed axially, leaving the support and vein in contact to form the venous graft. Over-extension of the tubular support is prevented using a length-limiting central thread or other means, as described above. As required, the vein segment is then inflated under arterial blood pressures of 120 mm of Hg, causing it to contact the tubular support inner lumenal surfaces. In certain embodiments, an adhesive securing the tubular support to the vein will ensure that the vein does not collapse during the surgical procedure when no internal pressure is applied. Again, it should be recognized (without limitation) that this is one of several ways to accomplish the above objectives.
  • [0071]
    The following sequence may occur at this or another time during the procedure. One of the external anti-fraying rings or cuffs is slid to the end of the vein, and a typical double-S-cutting line is used to prepare the end for the first anastomoses. The thin cuff prevents fraying of the tubular support and also gives the vein tissue and tubular support a uniformity which makes the surgical process of stitching the vein to the host artery in an end-to-side fashion much easier. Another thin anti-fraying ring is then slid down from the applicator to a position where either a side-to-side anastomoses for a sequential graft is being performed, or where the vein is being cut at an appropriate graft length. The half of the sliding cuff which remains on the original vein will make the process of the anastomoses to the proximal host artery much easier. In the case of a coronary artery bypass graft, for example, the end of the remaining vein protected by the other half of the cuff is used for the next distal graft anastomoses.
  • [0072]
    As structures have become increasingly complex, not only in design but also in the range of material use, pure analytical methods have begun to fail in describing the behavior of such structures. Due to the scientific challenge of closely matching a vascular graft of the type described herein to a host, analytical methods are rendered somewhat obsolete. Development of a prosthetic vascular graft which mimics the mechanical requirements and dynamic compliance of a normal healthy artery is made possible, however, with certain old tools, particularly cut and try methods in which incremental changes are made to the material or structure of the tubular support to modify its compliance properties, and the resulting properties are used to guide further changes. Empirical data or constitutive equations and mathematical analyses may be used for certain features. Alternatively, the use of numerical modeling with such tools as, for example, Finite Element Models and Methods, relying on continuum mechanics, along with certain other tools makes this level of customization feasible.
  • [0073]
    While the embodiments of the invention described herein are presently preferred, various modifications and improvements can be made without departing from the spirit and scope of the invention. The scope of the invention is indicated by the appended claims, and all changes that fall within the meaning and range of equivalents are intended to be embraced therein.

Claims (10)

  1. 1. A graft comprising a radially-resilient generally tubular support in supportive contact with an ablumenal surface of an implant blood vessel segment for replacing or augmenting a native blood vessel, said support exhibiting a resilient compliance suitable for controlling radial expansion of said implant blood vessel segment to a predetermined extent consistent with normal physiological cyclic stretch of the native vessel.
  2. 2. A graft as in claim 1 comprising a saphenous vein graft.
  3. 3. A graft as in claim 2 wherein the native blood vessel is a coronary artery.
  4. 4. A graft as in claim 1 wherein said resilient compliance is between 3-30%/100 mm Hg.
  5. 5. A graft as in claim 1 wherein said support is a knit fiber or wire mesh.
  6. 6. A graft as in claim 5 wherein said knit fiber or wire mesh includes a shape memory alloy metal wire.
  7. 7. A graft as in claim 5 wherein said support is capable of expanding in diameter through resilient movement of the fibers or wires of the mesh to control radial expansion of said implant blood vessel segment.
  8. 8. A graft as in claim 5 wherein said fiber or wire mesh is polymeric.
  9. 9. A radially resilient generally tubular support for externally supporting an implant blood vessel segment in replacement or augmentation of a native blood vessel, said support exhibiting a resilient compliance in a manner suitable to provide the implant blood vessel segment with a controlled radial expansion when exposed to an implanted blood circulation pressure through a lumen of the implant blood vessel segment that exceeds a normal blood circulation pressure of the implant blood vessel segment when in its native setting, the controlled radial expansion being consistent with a normal physiological cyclic stretch of the native blood vessel.
  10. 10. A radially-resilient generally tubular support as in claim 9, comprising a knit mesh.
US13351591 2003-04-28 2012-01-17 Compliant Venous Graft Abandoned US20120116495A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US46622603 true 2003-04-28 2003-04-28
US10834360 US8057537B2 (en) 2003-04-28 2004-04-28 Compliant venous graft
US12388702 US8172746B2 (en) 2003-04-28 2009-02-19 Compliant venous graft
US13351591 US20120116495A1 (en) 2003-04-28 2012-01-17 Compliant Venous Graft

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13351591 US20120116495A1 (en) 2003-04-28 2012-01-17 Compliant Venous Graft

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12388702 Continuation US8172746B2 (en) 2003-04-28 2009-02-19 Compliant venous graft

Publications (1)

Publication Number Publication Date
US20120116495A1 true true US20120116495A1 (en) 2012-05-10

Family

ID=33418355

Family Applications (3)

Application Number Title Priority Date Filing Date
US10834360 Active 2029-12-09 US8057537B2 (en) 2003-04-28 2004-04-28 Compliant venous graft
US12388702 Active 2025-05-10 US8172746B2 (en) 2003-04-28 2009-02-19 Compliant venous graft
US13351591 Abandoned US20120116495A1 (en) 2003-04-28 2012-01-17 Compliant Venous Graft

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10834360 Active 2029-12-09 US8057537B2 (en) 2003-04-28 2004-04-28 Compliant venous graft
US12388702 Active 2025-05-10 US8172746B2 (en) 2003-04-28 2009-02-19 Compliant venous graft

Country Status (6)

Country Link
US (3) US8057537B2 (en)
EP (2) EP2335648A1 (en)
JP (1) JP4692902B2 (en)
CA (1) CA2523812C (en)
ES (1) ES2375566T3 (en)
WO (1) WO2004096095A3 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208323A1 (en) * 2007-01-30 2008-08-28 El-Kurdi Mohammed S Bioerodible wraps and uses therefor
US20110230955A1 (en) * 2008-11-24 2011-09-22 Vascular Graft Solutions Ltd. External stent
US8992594B2 (en) 2009-12-16 2015-03-31 Neograft Technologies, Inc. Graft devices and methods of use
US9155610B2 (en) 2011-12-13 2015-10-13 Neograft Technologies, Inc. System and atraumatic mandrel for creating graft devices
US9295541B2 (en) 2009-12-31 2016-03-29 Neograft Technologies, Inc. Graft devices and methods of fabrication
US20160131804A1 (en) * 2013-07-22 2016-05-12 Motorola Solutions, Inc. Display system for a communication device
US9445874B2 (en) 2010-07-19 2016-09-20 Neograft Technologies, Inc. Graft devices and methods of use
US9579224B2 (en) 2011-07-25 2017-02-28 Neograft Technologies, Inc. Vessel remodeling methods and devices for use in a graft device
US9622849B2 (en) 2009-10-28 2017-04-18 University of Pittsburgh—of the Commonwealth System of Higher Education Bioerodible wraps and uses therefor
US9656417B2 (en) 2010-12-29 2017-05-23 Neograft Technologies, Inc. System and method for mandrel-less electrospinning

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8574146B2 (en) * 2000-04-14 2013-11-05 Attenuex Technologies, Inc. Implant with high vapor pressure medium
US6682473B1 (en) * 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US20030055494A1 (en) * 2001-07-27 2003-03-20 Deon Bezuidenhout Adventitial fabric reinforced porous prosthetic graft
US20050131520A1 (en) 2003-04-28 2005-06-16 Zilla Peter P. Compliant blood vessel graft
US7998188B2 (en) * 2003-04-28 2011-08-16 Kips Bay Medical, Inc. Compliant blood vessel graft
WO2004096095A3 (en) 2003-04-28 2005-04-28 Medtronic Inc Compliant venous graft
CN1849104B (en) * 2003-07-16 2011-08-03 戴维·彼得·肖 Prosthetic valves for medical application
EP1827300A1 (en) * 2004-11-12 2007-09-05 Medtronic, Inc. Compliant blood vessel graft
EP1940316B1 (en) * 2005-09-26 2015-10-21 AttenueX Technologies, Inc. Pressure attenuation device
EP1839600A1 (en) * 2006-03-30 2007-10-03 Levitronix LLC Expandable conduit-guide
EP1839601A1 (en) * 2006-03-30 2007-10-03 Levitronix LLC Self-expanding cannula
US20090227026A1 (en) * 2008-02-14 2009-09-10 Rapoport H Scott Tissue engineering scaffolds
US8353814B2 (en) * 2008-10-09 2013-01-15 Kips Bay Medical, Inc. Apparatus and method for mounting an external scaffold to a vascular graft
EP2332499B1 (en) * 2009-12-11 2016-01-27 Biotronik VI Patent AG Endoprosthesis
WO2011130579A1 (en) 2010-04-14 2011-10-20 Abbott Cardiovascular Systems Inc. Intraluminal scaffold and method of making and using same
WO2012085807A1 (en) * 2010-12-19 2012-06-28 Inspiremd Ltd. Stent with sheath and metal wire retainer
WO2012084007A1 (en) * 2010-12-20 2012-06-28 Graftcraft I Göteborg Ab Removable stent and method of production
WO2012104842A8 (en) 2011-02-03 2013-02-21 Endospan Ltd. Implantable medical devices constructed of shape memory material
US9486341B2 (en) 2011-03-02 2016-11-08 Endospan Ltd. Reduced-strain extra-vascular ring for treating aortic aneurysm
EP2706953A1 (en) 2011-04-18 2014-03-19 Vascular Graft Solutions Ltd. External support for elongated bodily vessels
WO2012143925A1 (en) 2011-04-18 2012-10-26 Vascular Graft Solutions Ltd Devices and methods for deploying implantable sleeves over blood vessels
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
US9839510B2 (en) * 2011-08-28 2017-12-12 Endospan Ltd. Stent-grafts with post-deployment variable radial displacement
WO2013063190A1 (en) * 2011-10-25 2013-05-02 Neograft Technologies, Inc. Graft device with adhered fiber matrix
US8894563B2 (en) 2012-08-10 2014-11-25 Attenuex Technologies, Inc. Methods and systems for performing a medical procedure
CN105208969B (en) 2013-03-11 2017-10-20 恩多斯潘有限公司 The multi-component stent grafts for aortic dissection system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020066360A1 (en) * 2000-10-31 2002-06-06 Greenhalgh E. Skott Supported lattice for cell cultivation
US20030055494A1 (en) * 2001-07-27 2003-03-20 Deon Bezuidenhout Adventitial fabric reinforced porous prosthetic graft

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337673A (en) 1958-07-31 1967-08-22 Us Catheter & Instr Corp Uniformly corrugated prosthesis and process of making same
US3626947A (en) 1970-02-19 1971-12-14 Charles Howard Sparks Method and apparatus for vein and artery reenforcement
US3797485A (en) 1971-03-26 1974-03-19 Alza Corp Novel drug delivery device for administering drug into blood circulation in blood vessel
US3974526A (en) 1973-07-06 1976-08-17 Dardik Irving I Vascular prostheses and process for producing the same
US4173689A (en) * 1976-02-03 1979-11-06 University Of Utah Synthetic polymer prosthesis material
EP0130401B1 (en) 1983-06-06 1989-05-17 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel and process for preparing the same
EP0128501B1 (en) 1983-06-06 1989-03-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel and process for preparing the same
FR2556210B1 (en) * 1983-12-08 1988-04-15 Barra Jean Aubert Prothese vein and its production process
US4652264A (en) 1985-04-25 1987-03-24 American Cyanamid Company Prosthetic tubular article
EP0216149B1 (en) * 1985-08-23 1991-12-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel having excellent patency
JPH0262264B2 (en) * 1985-08-23 1990-12-25 Kanegafuchi Chemical Ind
DE3640745A1 (en) 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
US4956178A (en) * 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US4969896A (en) 1989-02-01 1990-11-13 Interpore International Vascular graft prosthesis and method of making the same
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
JPH03260178A (en) 1990-03-06 1991-11-20 Sato Hisao Production of water-absorbing and water-retaining flexible cloth
CA2045222A1 (en) * 1990-07-12 1992-01-13 Norman R. Weldon Composite biosynthetic graft
US5320100A (en) 1991-09-16 1994-06-14 Atrium Medical Corporation Implantable prosthetic device having integral patency diagnostic indicia
US5662713A (en) * 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US7101392B2 (en) 1992-03-31 2006-09-05 Boston Scientific Corporation Tubular medical endoprostheses
EP0633798B1 (en) 1992-03-31 2003-05-07 Boston Scientific Corporation Vascular filter
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5716395A (en) 1992-12-11 1998-02-10 W.L. Gore & Associates, Inc. Prosthetic vascular graft
US5628782A (en) 1992-12-11 1997-05-13 W. L. Gore & Associates, Inc. Method of making a prosthetic vascular graft
WO1994021197A1 (en) 1993-03-25 1994-09-29 C.R. Bard, Inc. Vascular graft
US5723004A (en) 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
DE4340755C1 (en) 1993-11-30 1995-06-29 Zurbruegg Heinz R vascular prosthesis
CA2160022C (en) 1994-02-07 2005-01-18 Keiji Igaki Stent device and stent supplying system
US5478349A (en) 1994-04-28 1995-12-26 Boston Scientific Corporation Placement of endoprostheses and stents
US5584876A (en) 1994-04-29 1996-12-17 W. L. Gore & Associates, Inc. Cell excluding sheath for vascular grafts
US5900433A (en) 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
CA2147547C (en) 1994-08-02 2006-12-19 Peter J. Schmitt Thinly woven flexible graft
WO1996011720A1 (en) * 1994-10-17 1996-04-25 Kabushikikaisha Igaki Iryo Sekkei Drug-releasing stent
US5913894A (en) 1994-12-05 1999-06-22 Meadox Medicals, Inc. Solid woven tubular prosthesis
US5681345A (en) 1995-03-01 1997-10-28 Scimed Life Systems, Inc. Sleeve carrying stent
US5556414A (en) * 1995-03-08 1996-09-17 Wayne State University Composite intraluminal graft
GB2298577B (en) * 1995-03-09 1999-02-17 Univ Bristol Arteriovenous bypass grafting
US6264684B1 (en) 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
WO1996038090A1 (en) 1995-06-01 1996-12-05 Moskovsky Gosudarstvenny Institut Stali I Splavov Tekhnologichesky Universitet Method of extravascular correction of the function of incompetent vein valves and an extravascular corrector for that purpose
RU2102016C1 (en) 1995-07-07 1998-01-20 Московский государственный институт стали и сплавов (технологический университет) Device for extravasal correction of function of main vein valves
US6053943A (en) 1995-12-08 2000-04-25 Impra, Inc. Endoluminal graft with integral structural support and method for making same
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
WO2000062828A1 (en) 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
JP2000509307A (en) 1996-04-30 2000-07-25 メドトロニック,インコーポレイテッド Manufacturing method of autologous fibrin sealant
FR2748199B1 (en) 1996-05-02 1998-10-09 Braun Celsa Sa Vascular prosthesis surgically anastomosable transcutaneous
US5769884A (en) 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US5728150A (en) 1996-07-29 1998-03-17 Cardiovascular Dynamics, Inc. Expandable microporous prosthesis
US5797887A (en) 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5868763A (en) 1996-09-16 1999-02-09 Guidant Corporation Means and methods for performing an anastomosis
US5824047A (en) * 1996-10-11 1998-10-20 C. R. Bard, Inc. Vascular graft fabric
US5755778A (en) 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
US6048360A (en) 1997-03-18 2000-04-11 Endotex Interventional Systems, Inc. Methods of making and using coiled sheet graft for single and bifurcated lumens
US6273913B1 (en) 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US5972017A (en) 1997-04-23 1999-10-26 Vascular Science Inc. Method of installing tubular medical graft connectors
GB9710905D0 (en) 1997-05-27 1997-07-23 Imperial College Stent for blood vessel
US6161399A (en) 1997-10-24 2000-12-19 Iowa-India Investments Company Limited Process for manufacturing a wire reinforced monolayer fabric stent
US6117166A (en) 1997-10-27 2000-09-12 Winston; Thomas R. Apparatus and methods for grafting blood vessel tissue
EP1032328A1 (en) 1997-11-25 2000-09-06 Triad Vascular Systems Inc. Layered endovascular graft
US6117535A (en) * 1998-01-14 2000-09-12 Cardiotech International, Inc. Biocompatible devices
US6187038B1 (en) 1998-04-08 2001-02-13 Sulzer Carbomedics Inc. Small bore biologic graft with therapeutic delivery system
US5989287A (en) 1998-05-06 1999-11-23 Av Healing Llc Vascular graft assemblies and methods for implanting same
JP4341050B2 (en) * 1998-06-05 2009-10-07 オルガノジェネシス インク. Vascular graft prosthesis that was created by the biological engineering
EP1083843A4 (en) 1998-06-05 2005-06-08 Organogenesis Inc Bioengineered vascular graft support prostheses
US6217609B1 (en) 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US6159239A (en) 1998-08-14 2000-12-12 Prodesco, Inc. Woven stent/graft structure
US6156064A (en) 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
US6113612A (en) 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6152937A (en) 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6077298A (en) 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
DE19910340A1 (en) 1999-03-09 2000-09-21 Juergen C Froelich Improved autologous vein graft
US6551351B2 (en) * 1999-07-02 2003-04-22 Scimed Life Systems Spiral wound stent
US6358275B1 (en) 1999-10-04 2002-03-19 Sulzer Carbomedics Inc. Tissue-derived vascular grafts and methods for making the same
US6364895B1 (en) 1999-10-07 2002-04-02 Prodesco, Inc. Intraluminal filter
US6375670B1 (en) 1999-10-07 2002-04-23 Prodesco, Inc. Intraluminal filter
CA2387514A1 (en) 1999-10-08 2001-04-19 The General Hospital Corporation Percutaneous stent graft and method for vascular bypass
US6319279B1 (en) 1999-10-15 2001-11-20 Edwards Lifesciences Corp. Laminated self-sealing vascular access graft
US6346117B1 (en) 2000-03-02 2002-02-12 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6391037B1 (en) 2000-03-02 2002-05-21 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
JP2003531685A (en) * 2000-04-28 2003-10-28 エモリー ユニバーシテイ Decellularized vascular prosthesis
US20020083820A1 (en) 2000-10-10 2002-07-04 Greenhalgh E. Skott Stiffened fabric
US6814754B2 (en) 2000-10-30 2004-11-09 Secant Medical, Llc Woven tubular graft with regions of varying flexibility
US6494909B2 (en) 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US6551352B2 (en) 2001-05-03 2003-04-22 Bionx Implants, Inc. Method for attaching axial filaments to a self expanding stent
US20030110830A1 (en) * 2001-07-23 2003-06-19 Mark Dehdashtian Methods and apparatuses for measuring the compliance of stents and stented grafts
DE10137414B4 (en) * 2001-07-31 2005-12-29 Aesculap Ag & Co. Kg Sheath for use in surgery and veins
US20030204249A1 (en) 2002-04-25 2003-10-30 Michel Letort Endovascular stent graft and fixation cuff
US20040019375A1 (en) 2002-07-26 2004-01-29 Scimed Life Systems, Inc. Sectional crimped graft
US7011676B2 (en) 2002-09-05 2006-03-14 Scimed Life Systems, Inc. Flat knitted stent and method of making the same
US7264631B2 (en) 2002-09-16 2007-09-04 Scimed Life Systems, Inc. Devices and methods for AAA management
JP4373337B2 (en) 2002-12-19 2009-11-25 ニューサウス イノベイションズ ピーティーワイ リミテッド A method of treatment of hardened blood vessels
US7452374B2 (en) 2003-04-24 2008-11-18 Maquet Cardiovascular, Llc AV grafts with rapid post-operative self-sealing capabilities
US20050131520A1 (en) 2003-04-28 2005-06-16 Zilla Peter P. Compliant blood vessel graft
WO2004096095A3 (en) 2003-04-28 2005-04-28 Medtronic Inc Compliant venous graft
US6916336B2 (en) 2003-06-09 2005-07-12 Avantec Vascular Corporation Vascular prosthesis
DE10355986A1 (en) 2003-11-27 2005-06-30 Forschungszentrum Karlsruhe Gmbh compression sleeve
US20050177224A1 (en) 2004-02-11 2005-08-11 Fogarty Thomas J. Vascular fixation device and method
US20060069426A1 (en) 2004-09-27 2006-03-30 Weinberger Judah Z Methods and devices for extravascular intervention
WO2006050537A2 (en) 2004-11-03 2006-05-11 Cook Incorporated Methods for treating valve-associated regions of vascular vessels
JP4497057B2 (en) 2005-08-23 2010-07-07 日産自動車株式会社 Shift control device for a vehicle
US8702787B2 (en) 2005-09-02 2014-04-22 Medtronic Vascular, Inc. Endoluminal prosthesis
US8663308B2 (en) 2005-09-19 2014-03-04 Cook Medical Technologies Llc Graft with bioabsorbable support frame
JP2009514656A (en) 2005-11-09 2009-04-09 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Grafts and stent graft having radiopaque beading
US8778008B2 (en) 2006-01-13 2014-07-15 Aga Medical Corporation Intravascular deliverable stent for reinforcement of vascular abnormalities
US7481836B2 (en) 2006-03-30 2009-01-27 Medtronic Vascular, Inc. Prosthesis with coupling zone and methods
US8147537B2 (en) 2006-06-16 2012-04-03 The Invention Science Fund I, Llc Rapid-prototyped custom-fitted blood vessel sleeve
US7575592B2 (en) 2006-10-03 2009-08-18 St. Jude Medical, Inc. Synthetic blood vessel grafts

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020066360A1 (en) * 2000-10-31 2002-06-06 Greenhalgh E. Skott Supported lattice for cell cultivation
US20030055494A1 (en) * 2001-07-27 2003-03-20 Deon Bezuidenhout Adventitial fabric reinforced porous prosthetic graft

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208323A1 (en) * 2007-01-30 2008-08-28 El-Kurdi Mohammed S Bioerodible wraps and uses therefor
US9333068B2 (en) 2007-01-30 2016-05-10 University of Pittsburgh—of the Commonwealth System of Higher Education Bioerodible wraps and uses therefor
US9237945B2 (en) 2007-01-30 2016-01-19 University of Pittsburgh—of the Commonwealth System of Higher Education Bioerodible wraps and uses therefor
US9265632B2 (en) 2008-11-24 2016-02-23 Vascular Graft Solutions Ltd. Methods of supporting a vein
US20110230955A1 (en) * 2008-11-24 2011-09-22 Vascular Graft Solutions Ltd. External stent
US8734503B2 (en) 2008-11-24 2014-05-27 Vascular Graft Solutions Ltd. External stent
US9622849B2 (en) 2009-10-28 2017-04-18 University of Pittsburgh—of the Commonwealth System of Higher Education Bioerodible wraps and uses therefor
US8992594B2 (en) 2009-12-16 2015-03-31 Neograft Technologies, Inc. Graft devices and methods of use
US9603729B2 (en) 2009-12-16 2017-03-28 Neograft Technologies, Inc. Graft devices and related systems and methods
US9295541B2 (en) 2009-12-31 2016-03-29 Neograft Technologies, Inc. Graft devices and methods of fabrication
US9445874B2 (en) 2010-07-19 2016-09-20 Neograft Technologies, Inc. Graft devices and methods of use
US9656417B2 (en) 2010-12-29 2017-05-23 Neograft Technologies, Inc. System and method for mandrel-less electrospinning
US9579224B2 (en) 2011-07-25 2017-02-28 Neograft Technologies, Inc. Vessel remodeling methods and devices for use in a graft device
US9155610B2 (en) 2011-12-13 2015-10-13 Neograft Technologies, Inc. System and atraumatic mandrel for creating graft devices
US20160131804A1 (en) * 2013-07-22 2016-05-12 Motorola Solutions, Inc. Display system for a communication device

Also Published As

Publication number Publication date Type
EP1626679B1 (en) 2011-11-02 grant
US8172746B2 (en) 2012-05-08 grant
JP2006524556A (en) 2006-11-02 application
CA2523812A1 (en) 2004-11-11 application
JP4692902B2 (en) 2011-06-01 grant
US8057537B2 (en) 2011-11-15 grant
US20050070995A1 (en) 2005-03-31 application
EP2335648A1 (en) 2011-06-22 application
WO2004096095A2 (en) 2004-11-11 application
WO2004096095A3 (en) 2005-04-28 application
US20090163987A1 (en) 2009-06-25 application
EP1626679A2 (en) 2006-02-22 application
ES2375566T3 (en) 2012-03-02 grant
CA2523812C (en) 2011-06-21 grant

Similar Documents

Publication Publication Date Title
US5957949A (en) Percutaneous placement valve stent
US6494909B2 (en) Endovascular valve
US6312458B1 (en) Tubular structure/stent/stent securement member
US6315791B1 (en) Self-expanding prothesis
US6436132B1 (en) Composite intraluminal prostheses
US6237460B1 (en) Method for preparation of a self-expanding stent for a medical device to be introduced into a cavity of a body
US6878160B2 (en) Stent with controlled expansion
US6123723A (en) Delivery system and method for depolyment and endovascular assembly of multi-stage stent graft
US5782907A (en) Involuted spring stent and graft assembly and method of use
US7288111B1 (en) Flexible stent and method of making the same
US7300458B2 (en) Medical implant having a curlable matrix structure
US5632772A (en) Expandable supportive branched endoluminal grafts
US5913896A (en) Interwoven dual sinusoidal helix stent
US20010041928A1 (en) Endovascular stent graft
US6468300B1 (en) Stent covered heterologous tissue
US5575818A (en) Endovascular stent with locking ring
US6929659B2 (en) Method of preventing the dislodgment of a stent-graft
US20020123790A1 (en) Enhanced engagement member for anchoring prosthetic devices in body lumen
US20090287145A1 (en) Devices and methods for treatment of abdominal aortic aneurysms
US20050228486A1 (en) Implantable frame with variable compliance
US8333799B2 (en) Highly flexible stent and method of manufacture
US20130060323A1 (en) Braided helical wire stent
EP0565251B1 (en) Vascular stent
US6254627B1 (en) Non-thrombogenic stent jacket
US8021413B2 (en) Low profile medical device